Advertisement

Topics

EU expands indication of Alexion's Soliris

05:28 EDT 23 Aug 2017 | SmartBrief

Alexion Pharmaceuticals received approval from the European Commission to expand the indication for Soliris, or eculizumab, t -More

Original Article: EU expands indication of Alexion's Soliris

NEXT ARTICLE

More From BioPortfolio on "EU expands indication of Alexion's Soliris"

Advertisement
Quick Search
Advertisement
Advertisement